Royal Marsden NHS Foundation Trust
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
The Use of a Quality of Life Questionnaire in Patients With Lung Cancer
Not Applicable
- Conditions
- Lung Cancer
- Interventions
- Other: InterventionOther: AttentionOther: Control
- First Posted Date
- 2010-10-04
- Last Posted Date
- 2010-10-21
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 138
- Registration Number
- NCT01213745
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, Sutton, United Kingdom
Comparison of the Diagnostic Accuracy of 3D Volume Acquisition MRI With CT in Staging Colonic Cancer
Completed
- Conditions
- Colon Cancer
- First Posted Date
- 2010-08-24
- Last Posted Date
- 2017-06-20
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 60
- Registration Number
- NCT01187641
- Locations
- π¬π§
The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer
Not Applicable
Completed
- Conditions
- Colorectal CancerFallopian Tube CancerSarcomaRadiation ToxicityBladder CancerCervical CancerOvarian CancerAnal CancerGastrointestinal Complications
- First Posted Date
- 2010-07-27
- Last Posted Date
- 2016-11-01
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 177
- Registration Number
- NCT01170299
- Locations
- π¬π§
Royal Marsden - London, London, England, United Kingdom
Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer
Phase 3
- Conditions
- Bladder CancerCervical CancerColorectal CancerEndometrial CancerGastrointestinal ComplicationsLong-term Effects Secondary to Cancer Therapy in AdultsOvarian CancerProstate CancerRadiation ToxicitySarcoma
- First Posted Date
- 2010-03-16
- Last Posted Date
- 2011-07-15
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 75
- Registration Number
- NCT01087268
- Locations
- π¬π§
Royal Marsden - Surrey, Sutton, England, United Kingdom
A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU)
Phase 2
Terminated
- Conditions
- Pancreatic Cancer
- Interventions
- Other: UFT/ Leucovorin + Cetuximab + RadiotherapyOther: UFT, Leucovorin
- First Posted Date
- 2010-01-15
- Last Posted Date
- 2016-10-14
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 17
- Registration Number
- NCT01050426
- Locations
- π¬π§
Poole Hospital NHS Trust, Poole, United Kingdom
π¬π§Aberdeen Royal Infirmary, Aberdeen, United Kingdom
π¬π§Kent Oncology Centre, Tunbridge Wells, Maidstone, United Kingdom
Avoiding Surgery in Rectal Cancer After Pre-Operative Therapy
Phase 2
- Conditions
- Rectal Adenocarcinoma
- First Posted Date
- 2010-01-13
- Last Posted Date
- 2019-06-13
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 99
- Registration Number
- NCT01047969
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, London, United Kingdom
Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic Cancer
Phase 1
Completed
- Conditions
- Advanced Pancreatic Cancer
- Interventions
- First Posted Date
- 2010-01-13
- Last Posted Date
- 2012-09-25
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 36
- Registration Number
- NCT01048320
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Partial Liver Radiotherapy for Unresectable Liver Metastases
Not Applicable
- Conditions
- Metastatic Colorectal Liver Cancer
- First Posted Date
- 2010-01-13
- Last Posted Date
- 2010-01-13
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 18
- Registration Number
- NCT01048216
- Locations
- π¬π§
Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Phase 2
- Conditions
- AdenocarcinomaAdenocarcinoma, MucinousNeoplasms by Histologic TypeNeoplasmsNeoplasms, Cystic, Mucinous, and SerousDigestive System NeoplasmsIntestinal DiseasesCarcinomaColorectal NeoplasmsDigestive System Diseases
- Interventions
- Other: Patients who have surgery at 12 weeks after radiotherapy/chemoradiotherapy
- First Posted Date
- 2009-12-21
- Last Posted Date
- 2018-09-17
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 237
- Registration Number
- NCT01037049
- Locations
- π¬π§
Poole Hospital NHS Foundation Trust, Poole, Dorset, United Kingdom
π§π·Hospital AlemΓ£o Oswaldo Cruz, Sao Paulo, Brazil
π¨π¦Jewish General Hospital, Montreal, Quebec, Canada
Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients Setting
Completed
- Conditions
- SarcomaMelanoma
- First Posted Date
- 2009-12-17
- Last Posted Date
- 2016-05-23
- Lead Sponsor
- Royal Marsden NHS Foundation Trust
- Target Recruit Count
- 250
- Registration Number
- NCT01034696
- Locations
- π¬π§
Royal Marsden Hospital, Sutton, Surrey, United Kingdom
Β© Copyright 2025. All Rights Reserved by MedPath